ImageneBio (IMA) Times Interest Earned (2020 - 2025)
ImageneBio (IMA) posted Times Interest Earned of -$9.18 for Q3 2025, up 97.69% sequentially from -$397.73 in Q2 2025, and down 183.6% YoY from $10.98 in Q3 2024.
ImageneBio (IMA) Times Interest Earned (2020 - 2025) Analysis & Trends
ImageneBio has reported Times Interest Earned for 6 years, with the latest figure at -$9.18 in Q3 2025.
- Quarterly Times Interest Earned fell 183.6% year-over-year to -$9.18 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$23.97 (up 74.0% YoY) and the FY2024 annual result came in at -$0.53, up 29.17% from the prior year.
- Times Interest Earned rose to -$9.18 in Q3 2025 per IMA's latest filing, from -$397.73 in the prior quarter.
- Over five years, Times Interest Earned peaked at $0.08 in Q4 2021 and troughed at -$399.67 in Q1 2025.
- A 5-year average of -$49.63 and a median of -$4.8 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2021 and 2023: Times Interest Earned surged 101.76% in 2021, then plunged 27641.72% in 2023.
- Over 5 years, Times Interest Earned stood at $0.08 in 2021, then plunged by 10328.75% to -$8.58 in 2022, then declined by 1.05% to -$8.67 in 2023, then gained by 20.53% to -$6.89 in 2024, then sank by 33.18% to -$9.18 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$9.18, -$397.73, and -$399.67 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.03 Bn | 131.18 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.93 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.95 Bn | 36.86 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.00 Bn | 9.60 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 1.42 |
| 10 | ImageneBio | 47.79 Mn | -87.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -9.18 |
| Jun 30, 2025 | -397.73 |
| Mar 31, 2025 | -399.67 |
| Dec 31, 2024 | -6.89 |
| Sep 30, 2024 | -3.24 |
| Jun 30, 2024 | -33.24 |
| Mar 31, 2024 | -58.23 |
| Dec 31, 2023 | -8.67 |
| Sep 30, 2023 | -4.80 |
| Jun 30, 2023 | -1.52 |
| Mar 31, 2023 | -7.62 |
| Dec 31, 2022 | -8.58 |
| Sep 30, 2022 | -0.02 |
| Jun 30, 2022 | -0.01 |
| Mar 31, 2022 | -2.93 |
| Dec 31, 2021 | 0.08 |
| Sep 30, 2021 | -0.42 |
| Jun 30, 2021 | -0.31 |
| Mar 31, 2021 | -0.09 |
| Dec 31, 2020 | -4.77 |